Concepedia

Laurien J. Zeverijn

LJ

Statistics

Publications

10

Citations

723

H-Index

10

Active since

2020

Affiliations

Leiden University Medical Center(Current)

Oncode Institute

The Netherlands Cancer Institute

University Medical Center Utrecht

Amsterdam University Medical Centers

Laurien J. Zeverijn is an author at Leiden University Medical Center specializing in oncology, cancer immunotherapy, and medicine.

ORCID

Publications per year

2020–2024

10

Publications

10

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

N. de Vries, Joris van de Haar, Vivien Veninga et al. · Nature · 2023 · 298 citations · Full text

, , +15

A pan-cancer analysis of the microbiome in metastatic cancer

Thomas Battaglia, Iris Mimpen, Joleen J.H. Traets et al. · Cell · 2024 · 193 citations · Full text

, , +17

Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

Louisa R. Hoes, Jade M. van Berge Henegouwen, Hanneke van der Wijngaart et al. · Clinical Cancer Research · 2022 · 87 citations · Full text

, , +17

Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol

Karlijn Verkerk, Birgit S. Geurts, Laurien J. Zeverijn et al. · The Lancet Regional Health - Europe · 2024 · 29 citations · Full text

, , +16

Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer

Jade M. van Berge Henegouwen, M. Jebbink, Louisa R. Hoes et al. · European Journal of Cancer · 2022 · 27 citations · Full text

, , +16

1–5 of 10